<strong>CIT</strong>2011www.citmd.comThursday, March 17, 20111:25 PM - One-Year Results of the FIREHAWKFirst-in-Man Study and Update on TARGET I TrialRun-Lin GaoFunction A, Level 1Live Case Session 4Endovascular InterventionCardiovascular Institute and Fu WaiHospital, Beijing9:30 AM-11:30 AMModerators: Neil E. Strickman, Ruiyan ZhangDiscussants: Luyue Gai, Yuqing Hou, LianjunHuang, D. Christopher Metzger, Fayaz Shawl,Yan Wang, Chiung-Jen Wu, Yinghua ZouOperators: Xiongjing Jiang, Craig M. Walker,Raghotham R. Patlola, Andrej SchmidtLive Case Session 5Structural Heart DiseaseCardiovascular Institute and Fu WaiHospital, Beijing11:30 AM-12:30 PMModerators: Jan Kovac, Shiliang JiangDiscussants: Jacek Bialkowski, Atila Iyisoy,Pham Gia Khai, Xiangqing Kong, XuewenQin, Witold Ruzyllo, Malgorzata Szkutnik,Zhiwei Zhang, Shihua Zhao, Daxin ZhouOperators: Zhongying Xu, Saibal Kar, Gejun ZhangLuncheon SymposiumFrom FIREBIRD to FIREHAWK: An ExcellenceWe Have Seen and Ever Since!Sponsored by MicroPort Medical12:40 PM-1:55 PMChairman: Martin B. LeonCo-Chairmen: Yong Huo, Weifeng Shen,Haichang Wang, Guosheng Fu, Liliana R.Grinfeld12:40 PM - FOCUS Update: A Large-ScaleRegistry Study of FIREBIRD 2 Cobalt-Chromium Alloyed Sirolimus-Eluting StentJunbo Ge12:55 PM - Update of DK-CRUSH III Trial:The Use of FIREBIRD 2 Stent in Left MainBifurcationShaoliang Chen1:10 PM - FIREBIRD for In-Stent Restenosisin Brazil: Clinical, Angiographic, and IVUSFollow-Up ResultsFausto Feres1:40 PM - Panel Discussion and Take-<strong>Home</strong>Message1:55 PM - AdjournLive Case Session 6Non-LM BifurcationCardiovascular Institute and Fu WaiHospital, Beijing2:00 PM-3:30 PMModerators: Alan C. Yeung, Yong HuoDiscussants: Alejandro Fajuri, Quan Fang,Mohammad Ishaq, Zening Jin, Vincent On-HingKwok, Swee Choon Ng, Kenan Ovunc, Pieter R.Stella, Wasan Udayachalerm, Zuyi YuanOperators: Maurice Buchbinder, Julie Logan,Costantino R. Costantini, Costantino O.Costantini, Shubin QiaoIVUS Interpreter: Akiko MaeharaLive Case Session 7LM and BifurcationsChinese PLA General Hospital, Beijing3:30 PM-5:00 PMModerators: Spencer B. King III, Jiyan ChenDiscussants: Wacin Buddhari, In-Ho Chae,Tiemin Jiang, Soo-Jin Kang, Zhanquan Li,Jianfang Luo, Fayaz Shawl, Chris Kwok-Yiu Wong, Joo-Young Yang, RobaayahZambahariOperators: Seung-Jung Park, Yaron Almagor,Toshiya MuramatsuLive Case Session 8LM Bifurcation and TAVICardiovascular Institute and Fu WaiHospital, Beijing5:00 PM-6:30 PMModerators: Martin B. Leon, Weifeng ShenDiscussants: Kam-Tim Chan, Lei Ge, SemaGüneri, Saibal Kar, Upendra Kaul, Jan Kovac,Jian Liu, Martin T. Rothman, Huay CheemTan, Yu WangOperators: Antonio Colombo, EberhardGrube, Yuejin Yang, Yongjian WuIVUS Interpreter: Gary S. MintzFunction B, Level 1Luncheon SymposiumA Generation beyond Cobalt ChromiumSponsored by Boston Scientific12:40 PM-1:55 PMChairmen: Yuejin Yang, Yaling Han, WeiminLi, Meng Wei12:40 PM - Opening Remarks12:45 PM - Experience of PROMUS Elementin Challenging CasesAntonio Colombo1:05 PM - Real World Experience onPROMUS Element StentHuay Cheem Tan1:25 PM - BSC Present and FutureKeith D. Dawkins1:45 PM - Panel Discussion and Take-<strong>Home</strong>Message1:55 PM - AdjournLate Breaking Trials2:00 PM-3:30 PMModerators: Martin B. Leon, Patrick W. SerruysDiscussants: Upendra Kaul, Spencer B. KingIII, Ajay J. Kirtane, Alexandra J. Lansky, WeiLi, Sameer Mehta, Pieter C. Smits, HarrySuryapranata, William Wijns, StephanWindecker2:00 PM - NOYA I: A ProspectiveRandomized Trial of NOYA Sirolimus-Eluting Stent with Biodegradable CoatingCompared to FIREBIRD 2 Sirolimus-ElutingStent with Durable Coating in Patients withCoronary Artery DiseaseRun-Lin Gao2:10 PM - Moderated DiscussionLead Discussant: Stephan Windecker027
<strong>CIT</strong>2011www.citmd.comThursday, March 17, 20112:15 PM - CREST-MI: Comparison of Safetyand Efficacy between CYPHER Stent andENDEAVOR Stent in Patients with Acute ST-Segment Elevation Myocardial InfarctionLefeng Wang2:25 PM - Moderated DiscussionLead Discussant: Ajay J. Kirtane2:30 PM - MICD-STEMI PCI: MulticenterInvestigation of Compound Danshen DrippingPills on Short-Term Clinical Events in Patientwith ST-Segment Elevation MyocardialInfarction Undergoing Primary PCIGuangping Li2:40 PM - Moderated DiscussionLead Discussant: Harry Suryapranata2:45 PM - JETSTENT: Role of ThrombectomyDevices during PCI in ST-Segment ElevationMyocardial InfarctionAlfredo E. Rodriguez2:55 PM - Moderated DiscussionLead Discussant: Sameer Mehta3:00 PM - DK-CRUSH IV: HemodynamicChange of FFR after DK Crush vs.Provisional T Stenting for CoronaryBifurcation LesionsFei Ye3:10 PM - Moderated DiscussionLead Discussant: Patrick W. SerruysChien Foundation Lecture3:15 PM - The Journey of PercutaneousCardiovascular Intervention in ChinaRun-Lin Gao3:27 PM - Presentations of Tribute and AwardHarry SuryapranataPCR & ESC Working Group on CardiovascularSurgery @ <strong>CIT</strong>All You Need to Know About Left Main and/orMultivessel Disease Revascularization in 20113:30 PM-6:30 PMModerator: Jean MarcoCo-Moderator: Run-Lin GaoDiscussants: Shaoliang Chen, Yundai Chen, EricEeckhout, Tian-Hai Koh, Michael Kang-Yin Lee,Marie-Claude Morice, Teguh Santoso, Patrick W.Serruys, David P. Taggart, William Wijns3:30 PM - Introduction and ObjectivesJean Marco3:35 PM - Background: Why Three-VesselDisease Is Different?David P. Taggart3:45 PM - Background: Why Left Main StemDisease Is Different?Eric Eeckhout3:55 PM - Clinical Data: A Journey fromCABRI to SYNTAX and BeyondPatrick W. Serruys4:05 PM - Issues in Clinical Practice/Technical Aspects: Technique of Left MainStem/Multivessel Disease PercutaneousCoronary InterventionMarie-Claude Morice4:15 PM - Live in-a-Box on Left MainInvolving Bifurcation from Clinique Pasteur,Toulouse, France and DiscussionOperator: Jean Fajadet4:55 PM - Live in-a-Box from InstitutCardiovasculaire Paris Sud, Massy, Franceand DiscussionOperators: Marie-Claude Morice, ThierryLefèvre, Jean Fajadet5:35 PM - Guidelines/Recommendations:ESC/EACTS Guidance on Revascularizationand Perspective for Chinese CardiologistsDavid P. Taggart5:45 PM - Unresolved Issues/Outlook: Howto Integrate Comorbidity Factors, LocalExperience, and Patient Preferences intoDecision Making ProcessWilliam Wijns5:55 PM - Q&A: Crossfire between Chineseand European Interventional Cardiologists(Specificity of China)6:10 PM - Highlights of the Clinical TrialsMaking the Most Impact in Europe: Drug-Eluting Balloons, Drug-Eluting Stents, andBioresorbable Vascular ScaffoldPatrick W. Serruys6:25 PM - Wrap up and Key MessageJean Marco6:30 PM - AdjournFunction C, Level 1Luncheon SymposiumChallenge and Breakthrough in DESTechnologies: BuMA TM - A Drug-ElutingStent Who Can Ensure Perfect Re-EndothelializationSponsored by Sino Medical12:40 PM-1:55 PMChairmen: Jiyan Chen, Junbo Ge, Weimin Wang12:40 PM - Opening Remarks12:42 PM - Importance of Re-Endothelialization after DES ImplantationDue to Endothelia Cells’ FunctionalMechanismYundai Chen1:02 PM - Update of PANDA-I Clinical StudyShuzheng Lu1:22 PM - Case Review 1: Clinical Use ofBuMA DESJiyan Chen1:37 PM - Case Review 2: Clinical Use ofBuMA DESShaoliang Chen1:52 PM - Take-<strong>Home</strong> Message1:55 PM - Adjourn028
- Page 9 and 10: CIT2011www.citmd.comWelcome Message
- Page 11 and 12: CIT2011www.citmd.comOrganizationLuy
- Page 13 and 14: CIT2011www.citmd.comOrganizationSid
- Page 15 and 16: CIT2011www.citmd.comOrganizationChi
- Page 17 and 18: CIT2011www.citmd.comOrganizationShe
- Page 19: CIT2011www.citmd.comOrganizationSha
- Page 22 and 23: CIT2011www.citmd.comPROGRAM AT A GL
- Page 24 and 25: www.citmd.comCIT2011 www.citmd.comW
- Page 26 and 27: CIT2011www.citmd.comWednesday, marc
- Page 28 and 29: CIT2011www.citmd.comWednesday, marc
- Page 30 and 31: CIT2011www.citmd.comWednesday, marc
- Page 32 and 33: CIT2011www.citmd.comWednesday, marc
- Page 36 and 37: CIT2011www.citmd.comThursday, March
- Page 38 and 39: CIT2011www.citmd.comThursday, March
- Page 40 and 41: CIT2011www.citmd.comThursday, March
- Page 42 and 43: CIT2011www.citmd.comThursday, March
- Page 44 and 45: CIT2011www.citmd.comFriday, March 1
- Page 46 and 47: CIT2011www.citmd.comFriday, March 1
- Page 48 and 49: CIT2011www.citmd.comFriday, March 1
- Page 50 and 51: CIT2011www.citmd.comFriday, March 1
- Page 52 and 53: CIT2011www.citmd.comFriday, March 1
- Page 54 and 55: CIT2011www.citmd.comFriday, March 1
- Page 56 and 57: CIT2011www.citmd.comFriday, March 1
- Page 58 and 59: CIT2011www.citmd.comSaturday, March
- Page 60 and 61: CIT2011www.citmd.comSaturday, March
- Page 62 and 63: CIT2011www.citmd.comSaturday, March
- Page 64 and 65: CIT2011www.citmd.comSaturday, March
- Page 66 and 67: CIT2011www.citmd.comSaturday, March
- Page 68 and 69: CIT2011www.citmd.comSaturday, March
- Page 70 and 71: CIT2011www.citmd.comE-POSTER PROGRA
- Page 72 and 73: CIT2011www.citmd.comE-POSTER PROGRA
- Page 74 and 75: CIT2011www.citmd.comE-POSTER PROGRA
- Page 76 and 77: CIT2011www.citmd.com欢 迎 辞各
- Page 78 and 79: CIT2011www.citmd.com大 会 组 织
- Page 80 and 81: CIT2011www.citmd.com大 会 组 织
- Page 82 and 83: CIT2011www.citmd.com大 会 组 织
- Page 84 and 85:
CIT2011www.citmd.com大 会 组 织
- Page 86 and 87:
CIT2011www.citmd.com会 议 信 息
- Page 88 and 89:
CIT2011www.citmd.com日 程 一 览
- Page 90 and 91:
www.citmd.comCIT2011 www.citmd.comW
- Page 92 and 93:
CIT2011www.citmd.com2011 年 3 月
- Page 94 and 95:
CIT2011www.citmd.com2011 年 3 月
- Page 96 and 97:
CIT2011www.citmd.com2011 年 3 月
- Page 98 and 99:
CIT2011www.citmd.com2011 年 3 月
- Page 100 and 101:
CIT2011www.citmd.com2011 年 3 月
- Page 102 and 103:
CIT2011www.citmd.com2011 年 3 月
- Page 104 and 105:
CIT2011www.citmd.com2011 年 3 月
- Page 106 and 107:
CIT2011www.citmd.com2011 年 3 月
- Page 108 and 109:
CIT2011www.citmd.com2011 年 3 月
- Page 110 and 111:
CIT2011www.citmd.com2011 年 3 月
- Page 112 and 113:
CIT2011www.citmd.com2011 年 3 月
- Page 114 and 115:
CIT2011www.citmd.com2011 年 3 月
- Page 116 and 117:
CIT2011www.citmd.com2011 年 3 月
- Page 118 and 119:
CIT2011www.citmd.com2011 年 3 月
- Page 120 and 121:
CIT2011www.citmd.com2011 年 3 月
- Page 122 and 123:
CIT2011www.citmd.com2011 年 3 月
- Page 124 and 125:
CIT2011www.citmd.com2011 年 3 月
- Page 126 and 127:
CIT2011www.citmd.com2011 年 3 月
- Page 129 and 130:
CIT2011www.citmd.com2011 年 3 月
- Page 131 and 132:
CIT2011www.citmd.comCIT Hands-on Ce
- Page 133 and 134:
CIT2011www.citmd.comCIT Hands-on Ce
- Page 135 and 136:
CIT2011www.citmd.comCIT Hands-on Ce
- Page 137 and 138:
CIT2011www.citmd.comPROGRAM FOR CIT
- Page 139 and 140:
CIT2011www.citmd.comEXHIBITORS 参
- Page 141 and 142:
CIT2011www.citmd.comEXHIBITORS' DIR
- Page 143 and 144:
CIT2011www.citmd.comEXHIBITORS' DIR
- Page 145 and 146:
CIT2011www.citmd.comEXHIBITORS' DIR
- Page 147 and 148:
CIT2011www.citmd.comEXHIBITORS' DIR
- Page 149 and 150:
CIT2011www.citmd.comEXHIBITORS' DIR
- Page 151 and 152:
CIT2011www.citmd.comEXHIBITORS' DIR
- Page 153 and 154:
CIT2011www.citmd.comEXHIBITORS' DIR
- Page 155:
CIT2011www.citmd.comEXHIBITORS' DIR
- Page 158 and 159:
CIT2011www.citmd.comEXHIBITORS' DIR
- Page 160 and 161:
CIT2011www.citmd.comEXHIBITORS' DIR
- Page 162 and 163:
CIT2011www.citmd.comEXHIBITORS' DIR
- Page 164 and 165:
CIT2011www.citmd.comCIT2011www.citm
- Page 167 and 168:
CIT2011www.citmd.comAcknowledgment